The anti-angiogenic herbal composition Ob-X from Morus alba, Melissa officinalis, and Artemisia capillaris regulates obesity in genetically obese ob/ob mice

Pharmaceutical Biology

Volumn 49, Issue 6, 2011, Pages 614-619

  Yoon, Michung ^a   Kim, Min Young ^b  

^a Mokwon University   (South Korea)

^b AngioLab Inc   (South Korea)

Author keywords

adipocyte; adipose tissue; Angiogenesis; anti angiogenic plants; visceral fat

Indexed keywords

ANGIOGENESIS INHIBITOR; GLUCOSE; MATRIGEL; OB X; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTEMISIA; ARTEMISIA CAPILLARIS; ARTICLE; CELL SIZE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MIXTURE; GLUCOSE BLOOD LEVEL; IN VIVO STUDY; INTRAABDOMINAL FAT; LIPID LIVER LEVEL; LIPID STORAGE; MALE; MELISSA OFFICINALIS; MORUS ALBA; MOUSE; MULBERRY; NONHUMAN; OBESITY; TREATMENT DURATION; WEIGHT REDUCTION;

ADIPOCYTES; ANIMALS; ARTEMISIA; BLOOD GLUCOSE; DOSE-RESPONSE RELATIONSHIP, DRUG; INTRA-ABDOMINAL FAT; LIPID METABOLISM; LIVER; MALE; MELISSA; MICE; MICE, INBRED C57BL; MICE, OBESE; MORUS; NEOVASCULARIZATION, PATHOLOGIC; OBESITY; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; WEIGHT GAIN;

ARTEMISIA CAPILLARIS; ASTERACEAE; LAMIACEAE; MELISSA OFFICINALIS; MORACEAE; MORUS ALBA; MUS;

EID: 79955797302     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2010.539617     Document Type: Article

References (25)

1. Bouloumié A, Lolmède K, Sengenès C, Galitzky J, Lafontan M. (2002). Angiogenesis in adipose tissue. Ann Endocrinol (Paris) 63:91-95. (Pubitemid 34538250)
2. Bråkenhielm E, Cao R, Gao B, Angelin B, Cannon B, Parini P, Cao Y. (2004). Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Circ Res 94:1579-1588. (Pubitemid 38856965)
3. Cao Y. (2010). Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Nat Rev Drug Discov 9:107-115.
4. Cao Y. (2007). Angiogenesis modulates adipogenesis and obesity. J Clin Invest 117:2362-2368. (Pubitemid 47494333)
5. Coleman DL. (1978). Obese and diabetes: Two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14:141-148. (Pubitemid 8286141)
6. Couillard C, Mauriège P, Imbeault P, Prud'homme D, Nadeau A, Tremblay A, Bouchard C, Després JP. (2000). Hyperleptinemia is more closely associated with adipose cell hypertrophy than with adipose tissue hyperplasia. Int J Obes Relat Metab Disord 24:782-788. (Pubitemid 30339278)
7. Crandall DL, Hausman GJ, Kral JG. (1997). A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation 4:211-232. (Pubitemid 127674006)
8. de Souza CJ, Eckhardt M, Gagen K, Dong M, Chen W, Laurent D, Burkey BF. (2001). Efects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. Diabetes 50:1863-1871. (Pubitemid 33641608)
9. Folkman J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27-31.
10. Friedman JM, Halaas JL. (1998). Leptin and the regulation of body weight in mammals. Nature 395:763-770. (Pubitemid 28485436)
11. Friedman JM, Leibel RL. (1992). Tackling a weighty problem. Cell 69:217-220.
12. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman JM. (1997). Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci USA 94:8878-8883. (Pubitemid 27335133)
13. Hobson B, Denekamp J. (1984). Endothelial proliferation in tumours and normal tissues: Continuous labelling studies. Br J Cancer 49:405-413. (Pubitemid 14125248)
14. Kim J, Park BY, Park EK, Lee HS, Halm JC, Bae KH, Kim MY. (2006). Screening of anti-angiogenic activity from plant extracts. Kor J Pharmacog 37:253-257.
15. Kim MY, Park BY, Lee HS, Park EK, Hahm JC, Lee J, Hong Y, Choi S, Park D, Lee H, Yoon M. (2010). Te anti-angiogenic herbal composition Ob-X inhibits adipose tissue growth in obese mice. Int J Obes (Lond) 34:820-830.
16. Kissebah AH. (1997). Central obesity: measurement and metabolic efects. Diabetes Rev 5:8-20. (Pubitemid 27198911)
17. Lee J, Chae K, Ha J, Park BY, Lee HS, Jeong S, Kim MY, Yoon M. (2008). Regulation of obesity and lipid disorders by herbal extracts from Morus alba, Melissa ofcinalis, and Artemisia capillaris in high-fat diet-induced obese mice. J Ethnopharmacol 115:263-270. (Pubitemid 350266269)
18. Lijnen HR. (2008). Angiogenesis and obesity. Cardiovasc Res 78:286-293. (Pubitemid 351556088)
19. Lijnen HR, Maquoi E, Hansen LB, Van Hoef B, Frederix L, Collen D. (2002). Matrix metalloproteinase inhibition impairs adipose tissue development in mice. Arterioscler Tromb Vasc Biol 22:374-379. (Pubitemid 34218741)
20. Liu L, Meydani M. (2003). Angiogenesis inhibitors may regulate adiposity. Nutr Rev 61:384-387. (Pubitemid 37444691)
21. Neels JG, Tinnes T, Loskutof DJ. (2004). Angiogenesis in an in vivo model of adipose tissue development. FASEB J 18:983-985. (Pubitemid 39561499)
22. Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K, Umesono K, Akanuma Y, Fujiwara T, Horikoshi H, Yazaki Y, Kadowaki T. (1998). Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 101:1354-1361. (Pubitemid 28145252)
23. Passaniti A, Taylor RM, Pili R, Guo Y, Long PV, Haney JA, Pauly RR, Grant DS, Martin GR. (1992). A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fbroblast growth factor. Lab Invest 67:519-528.
24. Rupnick MA, Panigrahy D, Zhang CY, Dallabrida SM, Lowell BB, Langer R, Folkman MJ. (2002). Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci USA 99:10730-10735.
25. Silverman KJ, Lund DP, Zetter BR, Lainey LL, Shahood JA, Freiman DG, Folkman J, Barger AC (1988). Angiogenic activity of adipose tissue. Biochem Biophys Res Commun 153:347-352.